207 related articles for article (PubMed ID: 37947028)
1. The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian's structure-process-outcome framework.
Wang Q; Liu S; Nie Z; Zhu Z; Fu Y; Zhang J; Wei X; Yang L; Wei X
J Glob Health; 2023 Nov; 13():04137. PubMed ID: 37947028
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Tiered-Pricing Framework on Generic Entry in Canada.
Zhang W; Sun H; Guh DP; Lynd LD; Hollis A; Grootendorst P; Anis AH
Int J Health Policy Manag; 2022 Jun; 11(6):768-776. PubMed ID: 33233033
[TBL] [Abstract][Full Text] [Related]
3. Impact of China's National Volume-Based Procurement on Drug Procurement Price, Volume, and Expenditure: An Interrupted Time Series Analysis in Tianjin.
Zhao B; Wu J
Int J Health Policy Manag; 2023; 12():7724. PubMed ID: 38618801
[TBL] [Abstract][Full Text] [Related]
4. Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price.
Roughead EE; Kim DS; Ong B; Kemp-Casey A
WHO South East Asia J Public Health; 2018 Sep; 7(2):99-106. PubMed ID: 30136668
[TBL] [Abstract][Full Text] [Related]
5. Impact of European pharmaceutical price regulation on generic price competition: a review.
Puig-Junoy J
Pharmacoeconomics; 2010; 28(8):649-63. PubMed ID: 20515079
[TBL] [Abstract][Full Text] [Related]
6. Improving access to medicines and beyond: the national volume-based procurement policy in China.
Zhu Z; Wang Q; Sun Q; Lexchin J; Yang L
BMJ Glob Health; 2023 Jul; 8(7):. PubMed ID: 37463786
[TBL] [Abstract][Full Text] [Related]
7. A mixed integer programming model for vaccine pricing within a group purchasing organization.
Yu Z; Keskinocak P; Orenstein WA; Toktay LB
Vaccine; 2024 Mar; 42(8):1892-1898. PubMed ID: 37977944
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966
[TBL] [Abstract][Full Text] [Related]
9. Determinants of drug prices: a systematic review of comparison studies.
Janssen Daalen JM; den Ambtman A; Van Houdenhoven M; van den Bemt BJF
BMJ Open; 2021 Jul; 11(7):e046917. PubMed ID: 34266841
[TBL] [Abstract][Full Text] [Related]
10. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
Mansfield SJ
Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
[TBL] [Abstract][Full Text] [Related]
11. High prices for generics in Australia - more competition might help.
Bulfone L
Aust Health Rev; 2009 May; 33(2):200-14. PubMed ID: 19563309
[TBL] [Abstract][Full Text] [Related]
12. An analysis of volumes, prices and pricing trends of the pediatric antiretroviral market in developing countries from 2004 to 2012.
Lee JSF; Sagaon Teyssier L; Dongmo Nguimfack B; Collins IJ; Lallemant M; Perriens J; Moatti JP
BMC Pediatr; 2016 Mar; 16():41. PubMed ID: 26979974
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical pricing in emerging markets: effects of income, competition, and procurement.
Danzon PM; Mulcahy AW; Towse AK
Health Econ; 2015 Feb; 24(2):238-52. PubMed ID: 24293058
[TBL] [Abstract][Full Text] [Related]
14. Modeling Tiered Pricing Frameworks: A Simulation Approach.
Moradpour J; Zhang W; Grootendorst P; Anis AH; Hollis A
Value Health; 2023 Mar; 26(3):351-358. PubMed ID: 36396022
[TBL] [Abstract][Full Text] [Related]
15. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
16. Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China.
Yuan J; Lu ZK; Xiong X; Jiang B
BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34518200
[TBL] [Abstract][Full Text] [Related]
17. Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus.
Yuan J; Lu ZK; Xiong X; Lee TY; Huang H; Jiang B
Front Pharmacol; 2022; 13():842944. PubMed ID: 35734415
[No Abstract] [Full Text] [Related]
18. [Risk sharing methods in middle income countries].
Inotai A; Kaló Z
Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
[TBL] [Abstract][Full Text] [Related]
19. National Volume-Based Procurement (NVBP) exclusively for insulin: towards affordable access in China and beyond.
Yuan J; Li M; Jiang X; Lu ZK
BMJ Glob Health; 2024 Jan; 9(1):. PubMed ID: 38232994
[TBL] [Abstract][Full Text] [Related]
20. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
Li DG; Joyce C; Mostaghimi A
JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]